Galvanize Therapeutics Inc: Valuation, Funding & Investors
Galvanize Therapeutics Inc is a commercial-stage medical technology company based in Redwood City, California, specializing in pioneering pulsed electric field (PEF) therapies. The company focuses on developing non-drug, non-thermal interventions for the treatment of solid tumors and chronic bronchitis, aiming to alter disease trajectories and improve patient outcomes. Galvanize is advancing its Aliya® PEF energy platform and RheOx® therapy, positioning itself as a leader in medical technology innovations for oncology and chronic lung disease.
Leadership & Board
Latest Estimated Valuation
- Total Amount Raised
- $100M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $100M
- Latest Funding Round
- Series C
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 03, 2025 | Series C | $100.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Norwest Venture Partners | Series C |
| Janus Henderson Investors | Series C |
| Fidelity Management & Research Company | Series C |
| Sofinnova Partners | Series C |
| Ally Bridge Group | Series C |
| Gilmartin Capital | Series C |
| Elevage Medical Technologies | Series C |
| Perceptive Xontogeny Venture Fund | Series C |
Similar Companies
A snapshot of private companies similar to Galvanize Therapeutics Inc, helping you discover and navigate related company profiles.
Related News and Analysis
